Erfan Tasdighi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Erfan Tasdighi has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Majid Valizadeh
Obesity Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Science, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran
5 shared publications - Maryam Mahdavi
Obesity Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Science, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran
4 shared publications - Davood Khalili
Prevention of Metabolic Disorders Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications - Farhad Hosseinpanah
Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications - Farzad Hadaegh
Prevention of Metabolic Disorders Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences Tehran Iran
2 shared publications - Fereidoun Azizi
Endocrine Research Center, Research Institute for Endocrine Disorders, Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences Tehran Iran
2 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
Prevalence and Patterns of E-Cigarette Use Among U.S. Adults: A Repeated Cross-Sectional Analysis of the All of Us Research Program, 2017–2023
Introduction: Large-scale, ongoing cohort studies may offer a complementary approach for monitoring population patterns of e-cigarette use alongside established national surveillance systems. This study assessed the prevalence and patterns of current and daily e-cigarette use among adults in the All of Us Research Program from 2017 to 2023 and compared observed patterns with those from established national surveys. Material and methods: This repeated cross-sectional analysis included adults aged 18 years or older who completed the All of Us Lifestyle Survey between 2017 and 2023. Current and daily e-cigarette use were ascertained through self-reported survey items. The analytic cohort was sex-balanced through random subsampling of female participants (1:1 ratio), and overall prevalence estimates were age-standardized to the 2020 U.S. Census adult age distribution. All analyses were descriptive. Results: The analytic sample included 418,772 participants. Age-standardized prevalence of current e-cigarette use was 6.1% (95% CI: 6.0–6.2), and daily use was 2.4% (95% CI: 2.3–2.4). Prevalence was highest among adults aged 18–24 years (13.3%), male participants (7.0%), and those with depression (7.5%). Annual current use prevalence rose from 3.8% in 2017 to 8.5% in 2023, with a dip to 4.5% in 2020. Among young adults reporting current e-cigarette use, the proportion reporting never combustible cigarette use grew from 51.5% in 2017 to 65.2% in 2023. Conclusions: E-cigarette use was most common among young adults, with patterns consistent with nationally representative datasets. These findings support the potential of the All of Us Research Program as a complementary resource for monitoring e-cigarette use.
- 3 September 2026
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
Open AccessPrevalence and Patterns of E-Cigarette Use Among U.S. Adults: A Repeated Cross-Sectional Analysis of the All of Us Research Program, 2017–2023
Introduction: Large-scale, ongoing cohort studies may offer a complementary approach for monitoring population patterns of e-cigarette use alongside established national surveillance systems. This study assessed the prevalence and patterns of current and daily e-cigarette use among adults in the All of Us Research Program from 2017 to 2023 and compared observed patterns with those from established national surveys. Material and methods: This repeated cross-sectional analysis included adults aged 18 years or older who completed the All of Us Lifestyle Survey between 2017 and 2023. Current and daily e-cigarette use were ascertained through self-reported survey items. The analytic cohort was sex-balanced through random subsampling of female participants (1:1 ratio), and overall prevalence estimates were age-standardized to the 2020 U.S. Census adult age distribution. All analyses were descriptive. Results: The analytic sample included 418,772 participants. Age-standardized prevalence of current e-cigarette use was 6.1% (95% CI: 6.0–6.2), and daily use was 2.4% (95% CI: 2.3–2.4). Prevalence was highest among adults aged 18–24 years (13.3%), male participants (7.0%), and those with depression (7.5%). Annual current use prevalence rose from 3.8% in 2017 to 8.5% in 2023, with a dip to 4.5% in 2020. Among young adults reporting current e-cigarette use, the proportion reporting never combustible cigarette use grew from 51.5% in 2017 to 65.2% in 2023. Conclusions: E-cigarette use was most common among young adults, with patterns consistent with nationally representative datasets. These findings support the potential of the All of Us Research Program as a complementary resource for monitoring e-cigarette use.
- 1 January 2022
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 32 (1) , 249-257
Association of childhood obesity phenotypes with early adulthood Carotid Intima-Media Thickness (CIMT): Tehran lipid and glucose study
- 1 January 2022
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 32 (1) , 249-257
Association of childhood obesity phenotypes with early adulthood Carotid Intima-Media Thickness (CIMT): Tehran lipid and glucose study
- 1 December 2021
- Published by Elsevier in Primary Care Diabetes
- Vol. 15 (6) , 1052-1057
Contribution of obesity in increasing type 2 diabetes prevalence in Iranian urban and rural adults during recent decade
- 1 December 2021
- Published by Elsevier in Primary Care Diabetes
- Vol. 15 (6) , 1052-1057
Contribution of obesity in increasing type 2 diabetes prevalence in Iranian urban and rural adults during recent decade
- 26 June 2021
- Published by Wiley in Pediatric Diabetes
- Vol. 22 (7) , 937-945
Association of obesity phenotypes in adolescents and incidence of early adulthood type 2 diabetes mellitus: Tehran lipid and glucose study
Objective Obesity and metabolic syndrome, which has an increasing prevalence among adolescence, are associated with metabolic abnormalities. This study investigates the role of adolescent obesity phenotypes in predicting the incidence of early adulthood type 2 diabetes mellitus (T2DM). Research Design and Methods Participants were divided into four obesity phenotypes: Metabolically healthy normal weight (MHNW), metabolically healthy obese (MHO), metabolically unhealthy normal weight (MUNW), and metabolically unhealthy obese (MUO). Multivariate-adjusted hazard ratios (HRs) were calculated for T2DM incidence. Results In this cohort study, 2306 Tehranian adolescents with an average age of 15.1 ± 2.4 years were included. The median (IQ 25–75) follow-up was 15.5 (12.8–17.1) years and the median (IQ 25–75) age of participants at the end of follow-up was 30 (26–32) years old. The incidence rate of T2DM during the early adulthood was [1.37 (95% CI: 0.89–2.10)] and [3.18 (95% CI: 2.44–4.16)] per 1000 person per year in boys and girls, respectively. MHO phenotype was not associated with an increased risk of T2DM for both sexes. Adjusted HRs for MUO were [4.30 95% CI (1.48–12.43)] and [3.39 95% CI (1.78–6.45)] in boys and girls, respectively. MUNW phenotype was associated with an increased risk of T2DM only in boys. After adjustment for adulthood BMI, all the phenotypes for both sexes lost their significance, except for boys with MUNW phenotype [HR = 3.46 95% CI (1.15–10.45)]. Conclusions Unhealthy obesity phenotypes; in contrast with MHO; had an increased risk of T2DM incidence, apart from girls with MUNW. After adjusting the adulthood BMI, all phenotypes turn insignificant, except for boys with MUNW.
- 26 June 2021
- Published by Wiley in Pediatric Diabetes
- Vol. 22 (7) , 937-945
Association of obesity phenotypes in adolescents and incidence of early adulthood type 2 diabetes mellitus: Tehran lipid and glucose study
Objective Obesity and metabolic syndrome, which has an increasing prevalence among adolescence, are associated with metabolic abnormalities. This study investigates the role of adolescent obesity phenotypes in predicting the incidence of early adulthood type 2 diabetes mellitus (T2DM). Research Design and Methods Participants were divided into four obesity phenotypes: Metabolically healthy normal weight (MHNW), metabolically healthy obese (MHO), metabolically unhealthy normal weight (MUNW), and metabolically unhealthy obese (MUO). Multivariate-adjusted hazard ratios (HRs) were calculated for T2DM incidence. Results In this cohort study, 2306 Tehranian adolescents with an average age of 15.1 ± 2.4 years were included. The median (IQ 25–75) follow-up was 15.5 (12.8–17.1) years and the median (IQ 25–75) age of participants at the end of follow-up was 30 (26–32) years old. The incidence rate of T2DM during the early adulthood was [1.37 (95% CI: 0.89–2.10)] and [3.18 (95% CI: 2.44–4.16)] per 1000 person per year in boys and girls, respectively. MHO phenotype was not associated with an increased risk of T2DM for both sexes. Adjusted HRs for MUO were [4.30 95% CI (1.48–12.43)] and [3.39 95% CI (1.78–6.45)] in boys and girls, respectively. MUNW phenotype was associated with an increased risk of T2DM only in boys. After adjustment for adulthood BMI, all the phenotypes for both sexes lost their significance, except for boys with MUNW phenotype [HR = 3.46 95% CI (1.15–10.45)]. Conclusions Unhealthy obesity phenotypes; in contrast with MHO; had an increased risk of T2DM incidence, apart from girls with MUNW. After adjusting the adulthood BMI, all phenotypes turn insignificant, except for boys with MUNW.
- 15 June 2021
- Published by Wiley in Journal of Diabetes
- Vol. 13 (11) , 905-914
Metabolic risk factors among prediabetic individuals and the trajectory toward the diabetes incidence
Aims This study investigates the trajectory of the risk factors of prediabetes progression to overt diabetes. Methods The study retrospectively investigated 1610 prediabetic individuals. The trajectory of metabolic indicators was investigated using the generalized estimated equation method with autoregressive working correlation structure through a linear model with the identity link function. Results During 15 years of follow-up, the trajectories of metabolic risk factors changed from three years before diabetes occurrence for FPG and 2-hPG, six years for WC, nine years for HDL-c, and earlier for BMI, TG, and TG/HDL ratio. It was shown that the differences in the trajectory of WC and HDL were stable after adjustment for other metabolic risk factors. The trajectories of FPG and 2-hPG remained stable after considering multiple insulin resistance markers. Conclusions Deterioration of metabolic risk factors status can be a predictor of diabetes many years before its occurrence, but the abrupt change in plasma glucose is evident three years before DM onset. It seems that HDL-c and WC trajectories are two independent predictors diabetes incidence. It was also found that when the rising trend in plasma glucose is started, preventive strategies to lessen insulin resistance might not be efficient.
- 15 June 2021
- Published by Wiley in Journal of Diabetes
- Vol. 13 (11) , 905-914
Metabolic risk factors among prediabetic individuals and the trajectory toward the diabetes incidence
Aims This study investigates the trajectory of the risk factors of prediabetes progression to overt diabetes. Methods The study retrospectively investigated 1610 prediabetic individuals. The trajectory of metabolic indicators was investigated using the generalized estimated equation method with autoregressive working correlation structure through a linear model with the identity link function. Results During 15 years of follow-up, the trajectories of metabolic risk factors changed from three years before diabetes occurrence for FPG and 2-hPG, six years for WC, nine years for HDL-c, and earlier for BMI, TG, and TG/HDL ratio. It was shown that the differences in the trajectory of WC and HDL were stable after adjustment for other metabolic risk factors. The trajectories of FPG and 2-hPG remained stable after considering multiple insulin resistance markers. Conclusions Deterioration of metabolic risk factors status can be a predictor of diabetes many years before its occurrence, but the abrupt change in plasma glucose is evident three years before DM onset. It seems that HDL-c and WC trajectories are two independent predictors diabetes incidence. It was also found that when the rising trend in plasma glucose is started, preventive strategies to lessen insulin resistance might not be efficient.
- 1 January 2020
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 14 (1) , 73-79
Sleeve gastrectomy vs gastric bypass in improvement of depressive symptoms following one year from bariatric surgery, Tehran Obesity Treatment Study (TOTS)
- 1 January 2020
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 14 (1) , 73-79
Sleeve gastrectomy vs gastric bypass in improvement of depressive symptoms following one year from bariatric surgery, Tehran Obesity Treatment Study (TOTS)
- Open Access
- 10 December 2018
- Published by Springer Nature
Can vitamin D reduce heart muscle damage after bypass surgery?
- 10 December 2018
- Published by Springer Nature
Open AccessCan vitamin D reduce heart muscle damage after bypass surgery?